Lewinson D, Harel Z, Shenzer P, Silbermann M, Hochberg Z
Laboratory of Musculoskeletal Research, Rappaport Family Institute for Research in the Medical Sciences, Technion-Israel Institute of Technology, Haifa.
Endocrinology. 1989 Feb;124(2):937-45. doi: 10.1210/endo-124-2-937.
Hypothyroidism was induced in young female Sprague-Dawley rats by the addition of methimazole (0.67 mg/ml) to drinking water for a period of 7 weeks (7-14 weeks of age). The responses of the articular cartilage, epiphyseal growth plate cartilage, epiphyseal trabecular bone, and metaphyseal trabecular bone in the proximal tibia were assessed by structural parameters. In addition, replacement therapies were introduced for the last 2 weeks of the experimental period. These included 0.7 U/kg BW human GH (hGH), 15 micrograms/kg BW L-T4 (T4), and a combination of hGH and T4 at the same doses. In the hypothyroid rats, the width of epiphyseal growth plate cartilage decreased by 27%, that of articular cartilage by 35%, epiphyseal trabecular bone volume by 30%, and metaphyseal trabecular bone volume by 66% relative to those in age-matched control tissues. T4 treatment led to a full restoration of the epiphyseal trabecular bone and surpassed by 40% the control value. The magnitude of the articular cartilage and the epiphyseal trabecular bone volume returned to control values, while that of metaphyseal trabecular bone was 68% of control values. Treatment with hGH did not improve the epiphyseal growth plate cartilage or articular cartilage. It did restore epiphyseal trabecular bone to almost normal values, but metaphyseal trabecular bone improved to only a small though significant level (45% of control value). The combination of T4 and hGH resulted in an additional enlargement in the width of the epiphyseal growth plate cartilage and an increase in metaphyseal trabecular bone volume compared to those in the T4 group. Qualitative examinations indicated that it was only in the T4 and T4 plus hGH groups that the lowest chondrocytes in the epiphyseal growth plate cartilage resumed their normal hypertrophied size. These results suggest that the change in the hypothyroid state do not rely solely on the lack of pituitary GH synthesis and secretion, as replacement by exogenous GH did not restore normal epiphyseal growth plate cartilage morphology or its remodeling into metaphyseal trabecular bone. Treatment with T4 (which restored endogenous pituitary GH to 30% of control levels) results in full recovery of the epiphyseal growth plate cartilage morphology along with its associated metaphyseal trabecular bone. In addition, it can also be concluded that the decrease in epiphyseal trabecular bone volume observed in the hypothyroid animals was due solely to the GH-deficient state that accompanied hypothyroidism.
通过在7周龄(7 - 14周龄)的年轻雌性斯普拉格 - 道利大鼠饮用水中添加甲巯咪唑(0.67毫克/毫升)诱导甲状腺功能减退。通过结构参数评估胫骨近端关节软骨、骨骺生长板软骨、骨骺小梁骨和干骺端小梁骨的反应。此外,在实验期的最后2周引入替代疗法。这些疗法包括0.7单位/千克体重的人生长激素(hGH)、15微克/千克体重的左旋甲状腺素(T4)以及相同剂量的hGH和T4组合。与年龄匹配的对照组织相比,甲状腺功能减退大鼠的骨骺生长板软骨宽度减少了27%,关节软骨宽度减少了35%,骨骺小梁骨体积减少了30%,干骺端小梁骨体积减少了66%。T4治疗使骨骺小梁骨完全恢复,且超过对照值40%。关节软骨和骨骺小梁骨体积的大小恢复到对照值,而干骺端小梁骨体积为对照值的68%。hGH治疗并未改善骨骺生长板软骨或关节软骨。它确实使骨骺小梁骨恢复到几乎正常的值,但干骺端小梁骨仅改善到一个虽小但显著的水平(对照值的45%)。与T4组相比,T4和hGH的组合导致骨骺生长板软骨宽度进一步增大,干骺端小梁骨体积增加。定性检查表明,只有在T4组和T4加hGH组中,骨骺生长板软骨中最低层的软骨细胞恢复了其正常的肥大尺寸。这些结果表明,甲状腺功能减退状态的变化并不完全依赖于垂体生长激素合成和分泌的缺乏,因为外源性生长激素替代并未恢复正常的骨骺生长板软骨形态或其向干骺端小梁骨的重塑。T4治疗(使内源性垂体生长激素恢复到对照水平的30%)导致骨骺生长板软骨形态及其相关的干骺端小梁骨完全恢复。此外,还可以得出结论,甲状腺功能减退动物中观察到的骨骺小梁骨体积减少仅归因于伴随甲状腺功能减退的生长激素缺乏状态。